Investor Relations
MissionArrayit stands at the center of a trend which is revolutionizing modern medicine by customizing treatment to a patient’s molecular and genetic profile. We develop, manufacture, and market a comprehensive line of microarray, life science tools, and integrated systems for the large-scale analysis of genetic variation and biological function. Through our versatile contact printing method, our technology can detect all 6,000 diseases and analyze a wide array of biomolecules, creating opportunities for effective testing and healthcare around the world.
Learn more about our highlights and statistics with the Arrayit Fact Sheet (PDF).
|
NavigateInvestor Relations
Conference Calls/Webcast Management Team Investor Presentation (PDF) SEC Filings Press Releases Shareholder FAQ's Arrayit Fact Sheet (PDF) Events and Presentations |